Neelja Singhal
Overview
Explore the profile of Neelja Singhal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
821
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
An integrated proteo-transcriptomics approach reveals novel drug targets against multidrug resistant
Aswal M, Singh N, Singhal N, Kumar M
Front Microbiol
. 2025 Mar;
16:1531739.
PMID: 40071204
Infections due to multidrug-resistant (MDR) are associated with severe morbidity and mortality, worldwide. Microbial drug resistance is a complex phenomenon which is conditioned by an interplay of several genomic, transcriptomic...
2.
Dabburu G, Garg A, Singhal N, Kumar M
In Silico Pharmacol
. 2025 Feb;
13(1):30.
PMID: 39974371
Graphical Abstract: Supplementary Information: The online version contains supplementary material available at 10.1007/s40203-025-00316-6.
3.
Jain A, Singhal N, Kumar M
Bioinformatics
. 2023 Nov;
39(11).
PMID: 37947313
Motivation: Fungal pathogens are known to cause life threatening invasive infections with rising global mortality rates. Besides, the indiscriminate use of antifungals in both clinics and agriculture has promoted antifungal...
4.
Aswal M, Singhal N, Kumar M
Sci Data
. 2023 Sep;
10(1):573.
PMID: 37658065
Escherichia coli are highly diverse bacteria with different pathogenic types, serotypes and phylogenetic types/phylotypes. In recent years, infections with E. coli have increased worldwide and so has the emergence of...
5.
Aswal M, Singhal N, Kumar M
Front Nutr
. 2023 Apr;
10:1082566.
PMID: 37081914
Hypercholesterolemia is a major risk factor for cardiovascular diseases (CVDs). Chemotherapeutic agents for CVDs exhibit several side effects. Specific probiotics with hypocholesterolemic effects can be safe and effective alternatives to...
6.
Pandey D, Singhal N, Kumar M
Front Microbiol
. 2023 Jan;
13:1039687.
PMID: 36713195
β-Lactams are a broad class of antimicrobial agents with a high safety profile, making them the most widely used class in clinical, agricultural, and veterinary setups. The widespread use of...
7.
Pandey D, Kumari B, Singhal N, Kumar M
Biol Methods Protoc
. 2022 Dec;
7(1):bpac031.
PMID: 36479434
Antibiotic resistance has escalated as a significant problem of broad public health significance. Regular surveillance of antibiotic resistance genes (ARGs) in microbes and metagenomes from human, animal and environmental sources...
8.
Garg A, Singhal N, Kumar M
Front Microbiol
. 2022 Nov;
13:1039188.
PMID: 36406429
No abstract available.
9.
Garg A, Dabburu G, Singhal N, Kumar M
PLoS One
. 2022 Apr;
17(4):e0265657.
PMID: 35421114
Microbial mimicry of the host proteins/peptides can elicit host auto-reactive T- or B-cells resulting in autoimmune disease(s). Since intrinsically disordered protein regions (IDPRs) are involved in several host cell signaling...
10.
Singh N, Singhal N, Kumar M, Virdi J
Epidemiol Infect
. 2022 Mar;
:1-21.
PMID: 35343419
No abstract available.